2009 annual financial data
Ernexa Therapeutics 2009 Operating cash flow margin
Direct answer
Operating cash flow margin was 9.7%.
Operating income was -1,501,000 USD and net income was -1,501,000 USD.
Operating cash flow was 2,503,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,814,000 USD
- Operating income
- -1,501,000 USD
- Net income
- -1,501,000 USD
- Operating cash flow
- 2,503,000 USD